Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Superfiliate Reviews & Ratings
    49 Ratings
    Company Website
  • Revaly Reviews & Ratings
    7 Ratings
    Company Website
  • AthenaHQ Reviews & Ratings
    50 Ratings
    Company Website
  • optivalue.ai Reviews & Ratings
    4 Ratings
    Company Website
  • Checksum.ai Reviews & Ratings
    2 Ratings
    Company Website
  • wp2print Reviews & Ratings
    7,748 Ratings
    Company Website
  • Pipedrive Reviews & Ratings
    12,537 Ratings
    Company Website
  • HubSpot AEO Reviews & Ratings
    151 Ratings
    Company Website
  • Dynamo Software Reviews & Ratings
    71 Ratings
    Company Website
  • SciSure Reviews & Ratings
    311 Ratings
    Company Website

What is Iktos?

Makya emerges as a groundbreaking user-focused SaaS platform specifically tailored for AI-driven de novo drug design, with a particular focus on Multi-Parametric Optimization (MPO). This cutting-edge tool enables users to generate original and easily synthesizable compounds through a multi-objective framework, achieving unparalleled speed, efficiency, and diversity in results. Featuring a variety of generative algorithms that cater to different phases of drug development—from hit discovery to lead optimization—Makya includes a fine-tuning generator for identifying optimal solutions within your defined chemical space, a novelty generator aimed at uncovering new ideas for re-scaffolding and hit identification, and a forward generator that assembles a specialized library of compounds ready for synthesis using commercially accessible starting materials. The platform's latest addition, the Makya 3D module, markedly enhances both the user experience and scientific functionality. With an extensive toolkit of 3D modeling capabilities for both ligand-based and structure-based methodologies, Makya 3D facilitates the computation of 3D scores that can be effortlessly integrated to steer compound generation within the platform. This comprehensive integration not only refines the design workflow but also provides researchers with profound insights into their molecular architectures, ultimately transforming the drug discovery landscape. As researchers increasingly seek innovative solutions, Makya stands at the forefront, revolutionizing the way compounds are designed and developed.

What is BIOVIA Discovery Studio?

The current landscape of the biopharmaceutical industry is marked by its complexity, spurred by rising expectations for greater specificity and safety, the introduction of novel treatment approaches, and an enriched comprehension of intricate disease mechanisms. To effectively navigate this multifaceted environment, it is crucial to have a solid understanding of therapeutic behavior. Advanced modeling and simulation methodologies provide a robust approach to exploring biological and physicochemical phenomena at the atomic level, which can significantly guide experimental research and accelerate both discovery and development phases. BIOVIA Discovery Studio integrates over thirty years of meticulously validated research with state-of-the-art in silico techniques such as molecular mechanics, free energy calculations, and biotherapeutic development, all within a single cohesive platform. This all-encompassing set of tools enables researchers to probe the intricacies of protein chemistry, thereby streamlining the discovery and optimization processes for both small and large molecule therapeutics, from target identification to lead optimization, ultimately improving the drug development workflow. In a time when precision medicine is becoming increasingly crucial, the availability of such advanced tools is essential for fostering therapeutic advancements and ensuring they meet the evolving needs of patients. The ongoing evolution of these technologies promises to further enhance the effectiveness and efficiency of the biopharmaceutical sector.

Media

Media

Integrations Supported

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python

Integrations Supported

API Availability

Has API

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS
On-Prem

Supported Platforms

SaaS

Customer Service / Support

Standard Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
On-Site Training

Training Options

Documentation Hub

Company Facts

Organization Name

Iktos

Company Location

France

Company Website

iktos.ai/makya/

Company Facts

Organization Name

Dassault Systèmes

Date Founded

1981

Company Location

France

Company Website

www.3ds.com/products-services/biovia/products/molecular-modeling-simulation/biovia-discovery-studio/

Categories and Features

Drug Discovery

Not specified

Categories and Features

Drug Discovery

Not specified

Life Sciences

Not specified

Molecular Modeling

Not specified

Popular Alternatives

AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA

Popular Alternatives

SILCS Reviews & Ratings

SILCS

SilcsBio
alvaModel Reviews & Ratings

alvaModel

Alvascience
alvaBuilder Reviews & Ratings

alvaBuilder

Alvascience